Ask Warren

NKGen Biotech Korea

182400 · KOSDAQ · ₩182400 · 엔케이젠바이오텍코리아

₩3,670 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩7.9B₩8.8B₩9.9B₩11B₩13B
Cost of sales₩1.2B₩1.7B₩3.6B₩2.5B₩3.7B
Gross profit₩6.7B₩7.1B₩6.4B₩8.7B₩9.3B
Operating income−₩2.5B−₩4.1B−₩67B−₩50B−₩47B
Net income−₩7.3B−₩37B−₩153B−₩56B−₩51B
Net income to shareholders−₩10B−₩37B−₩153B−₩54B−₩50B

Balance sheet

20252024202320222021
Total assets₩14B₩23B₩54B₩170B₩181B
Current assets₩6.6B₩10B₩8.9B₩25B₩30B
Cash and equivalents₩980M₩3.1B₩653M₩5.9B₩12B
Total liabilities₩7.2B₩48B₩64B₩86B₩61B
Current liabilities₩3.2B₩48B₩60B₩71B₩43B
Borrowings—₩37B₩6B——
Total equity₩7.1B−₩25B−₩9.3B₩83B₩120B
Shareholders' equity₩7.1B−₩25B−₩9.3B₩86B₩120B

Cash flow

20252024202320222021
Cash from operations−₩3.2B−₩1.3B−₩35B−₩38B−₩34B
Capital spending₩902M—₩672M₩926M₩1.4B
Free cash flow−₩4.1B−₩1.3B−₩36B−₩39B−₩36B

Consolidated where available. Amounts in won.

Also known as: NKGen Biotech Korea / 엔케이젠바이오텍코리아 / 182400 / KRX:182400

Source: KRX statistical information